enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Medications for Substance Use Disorders | SAMHSA

    www.samhsa.gov/medications-substance-use-disorders

    Body MAT Learn how medications can be used to treat substance use disorders, sustain recovery and prevent overdose. The use of medications, in combination with counseling and behavioral therapies , to provide a “whole-patient” approach to the treatment of substance use disorders.

  3. Medicated-Assisted Treatment Training Materials & Resources -...

    www.samhsa.gov/medications-substance-use-disorders/training-resources

    Waiver Elimination (MAT Act) Training Requirements (MATE Act) Resources. Recommendations for Curricular Elements in Substance Use Disorders Training; Professional Medical Membership and Training and Accreditation/Approval Organizations; Pharmacist Verification of Buprenorphine Providers. Buprenorphine Pharmacy Lookup

  4. What is Buprenorphine? Side Effects, Uses, Dose & Risk - SAMHSA

    www.samhsa.gov/medications-substance-use-disorders/medications-counseling...

    Waiver Elimination (MAT Act) Training Requirements (MATE Act) Resources. Recommendations for Curricular Elements in Substance Use Disorders Training; Professional Medical Membership and Training and Accreditation/Approval Organizations; Pharmacist Verification of Buprenorphine Providers. Buprenorphine Pharmacy Lookup

  5. Frequently Asked Questions for Buprenorphine Waiver Applicants -...

    www.samhsa.gov/medications-substance-use-disorders/waiver-elimination-mat-act

    Waiver Elimination (MAT Act) Main page content Section 1262 of the Consolidated Appropriations Act, 2023 (also known as Omnibus bill), removes the federal requirement for practitioners to submit a Notice of Intent (have a waiver) to prescribe medications, like buprenorphine, for the treatment of opioid use disorder (OUD).

  6. Medication-assisted Treatment Inside Correctional Facilities

    store.samhsa.gov/sites/default/files/pep19-mat-corrections.pdf

    Medication-assisted treatment (MAT) is the use of FDA-approved medications in combination with behavioral therapies to treat alcohol and opioid use disorders. When provided as part of the rehabilitation and reentry process for people incarcerated in correctional facilities, MAT addresses substance use as

  7. Rights for Individuals on Medication-Assisted Treatment

    www.samhsa.gov/sites/default/files/programs_campaigns/medication_assisted/Know...

    Assisted Treatment for opioid addiction (also known as “MAT”). MAT includes a medication (e.g., methadon e, buprenorphine, oral naltrexone) approved by the U.S. Food and Drug Administration (FDA) for opioid addiction detoxification or maintenance treatment.

  8. Statutes, Regulations, and Guidelines - SAMHSA

    www.samhsa.gov/medications-substance-use-disorders/statutes-regulations-guidelines

    Waiver Elimination (MAT Act) Training Requirements (MATE Act) Resources. Recommendations for Curricular Elements in Substance Use Disorders Training; Professional Medical Membership and Training and Accreditation/Approval Organizations; Pharmacist Verification of Buprenorphine Providers. Buprenorphine Pharmacy Lookup

  9. MEDICATION-ASSISTED TREATMENT (MAT) IN THE CRIMINAL JUSTICE...

    store.samhsa.gov/sites/default/files/pep19-matbriefcjs_0.pdf

    MAT is relevant at each point of contact across the justice system. At first contact between a law enforcement officer and individuals with an opioid use disorder (OUD), opportunities may exist to divert people directly to MAT treatment

  10. Prescription Drug and Opioid Addiction - SAMHSA

    www.samhsa.gov/grants/grant-announcements/ti-21-006

    The purpose of this program is to expand/enhance access to medication-assisted treatment (MAT) services for persons with an opioid use disorder (OUD) seeking or receiving MAT.

  11. What is Methadone? Effects, Risks & Addiction | SAMHSA

    www.samhsa.gov/medications-substance-use-disorders/medications-counseling...

    Methadone is a medication used to treat Opioid Use Disorder (OUD). Methadone is a long-acting full opioid agonist, and a schedule II controlled medication. Methadone used to treat those with a confirmed diagnosis of opioid use disorder (OUD) can only be dispensed through a SAMHSA certified OTP.